Related Experiment Video
Updated: Jul 2, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination
Brendan Moran1, Dario Baratti, Tristan D Yan
1Colorectal Research Unit, North Hampshire Hospital, Basingstoke, Hampshire, UK.
Abstract:
Pseudomyxoma peritonei (PMP) is a rare condition mostly originating from low malignant potential mucinous tumours of the appendix. Although this disease process is minimally invasive and rarely causes haematogenous or lymphatic metastases, expectation of long-term survival are limited with no prospect of cure. Recently, the combined approach of cytoreductive surgery (CRS) and perioperative loco-regional chemotherapy (PLC) has been proposed as the standard of treatment for the disease. The present paper summarizes the available literature data and the main features of the comprehensive loco-regional treatment of PMP. The controversial issues concerning the indications and technical methodology in PMP management were discussed through a web-based voting system by internationally known experts. Results were presented for further evaluation during a dedicated session of "The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006)". The experts agreed that multiple prospective trials support a benefit of the procedure in terms of improved survival, as compared with historical controls. Concerning the main controversial methodological questions, there was an high grade of consistency among the experts and agreement with the findings of the literature.
Insights
Cytoreductive surgery (CRS) combined with perioperative loco-regional chemotherapy (PLC) offers improved survival for pseudomyxoma peritonei (PMP). Experts reached consensus on treatment indications and methodology, supporting this approach for PMP management.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pseudomyxoma peritonei (PMP) is a rare appendiceal tumor with limited survival and no cure.
- Current treatments offer limited long-term survival prospects.
Purpose of the Study:
- To summarize literature on cytoreductive surgery (CRS) and perioperative loco-regional chemotherapy (PLC) for PMP.
- To discuss and reach consensus on controversial PMP management issues.
Main Methods:
- Literature review on CRS and PLC for PMP.
- Web-based expert voting system to discuss indications and methodology.
- Presentation of results at the Fifth International Workshop on Peritoneal Surface Malignancy.
Main Results:
- Experts agreed prospective trials support improved survival with CRS and PLC compared to historical controls.
- High consistency among experts on controversial methodological questions.
- Agreement with existing literature findings on PMP management.
Conclusions:
- The combined CRS and PLC approach is supported by evidence for improved PMP survival.
- Expert consensus was reached on key aspects of PMP treatment methodology and indications.
